Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL - CALGB 150007/150012, ACRIN 6657

Laura J. Esserman, Donald A. Berry, Angela DeMichele, Lisa Carey, Sarah E. Davis, Meredith Buxton, Cliff Hudis, Joe W. Gray, Charles Perou, Christina Yau, Chad Livasy, Helen Krontiras, Leslie Montgomery, Debasish Tripathy, Constance Lehman, Minetta C. Liu, Olufunmilayo I. Olopade, Hope S. Rugo, John T. Carpenter, Lynn DresslerDavid Chhieng, Baljit Singh, Carolyn Mies, Joseph Rabban, Yunn Yi Chen, Dilip Giri, Laura Van't Veer, Nola Hylton

Research output: Contribution to journalArticlepeer-review

279 Scopus citations

Fingerprint Dive into the research topics of 'Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: Results from the I-SPY 1 TRIAL - CALGB 150007/150012, ACRIN 6657'. Together they form a unique fingerprint.

Medicine & Life Sciences